Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1900 participants.

Also called NCT02617290

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,900 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02617290
Other papers using this trial's data
  • Definition and Prediction of Periprocedural Myocardial Infarction in Elective Percutaneous Coronary Intervention: The ALPHEUS-MI Study The Canadian journal of cardiology, 2026-11 DOI, PubMed 41763360
  • Impacts of stent characteristics on periprocedural ischemic events in elective PCI: the ALPHEUS-stents study International journal of cardiology, 2026-08-01 DOI, PubMed 41999954
  • Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Lancet (London, England), 2020-11-28 DOI, PubMed 33202219

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02617290. Randomized; no masking; primary purpose treatment. Start 2017-01-09 (actual); primary completion 2020-05-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
Acronym
ALPHEUS
Condition
Myocardial Ischemia
Condition
Stent Thrombosis
Condition
Cardiovascular Diseases
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)
Collaborator
Action Research Group (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct02617290
Content hash
b007b51e7847c802460dced78a3508717cc3ffff68b86ea50a4f95ec82303898